KLF9 and cancer: Although a direct mechanistic link between EC pathogenesis and KLF9 loss of expression has yet to be evaluated, our findings are consistent with the increasing validation of KLF9 tumor-suppressive functions in mouse models of cancer and in cancer cell lines [49–53].